CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-13 | Huang Jane CMO, Hematology | Sale | −200 | $94.53 | $19K | 0 |
| 2017-12-13 | Huang Jane CMO, Hematology | Exercise or conversion · Share Option (Right to Buy) | −19,500 | 1,380,500 | ||
| 2017-12-08 | OYLER JOHN Chief Executive Officer | Sale | −10,809 | $94.91 | $1.0M | 161,145 |
| 2017-12-08 | OYLER JOHN Chief Executive Officer | Sale | −37,208 | $95.62 | $3.6M | 123,937 |
| 2017-12-08 | OYLER JOHN Chief Executive Officer | Sale | −4,800 | $96.67 | $464K | 119,137 |
| 2017-12-07 | OYLER JOHN Chief Executive Officer | Sale | −24,080 | $92.06 | $2.2M | 207,611 |
| 2017-12-07 | OYLER JOHN Chief Executive Officer | Sale | −9,439 | $93.23 | $880K | 198,172 |
| 2017-12-07 | OYLER JOHN Chief Executive Officer | Sale | −13,213 | $93.94 | $1.2M | 184,959 |
| 2017-12-07 | OYLER JOHN Chief Executive Officer | Sale | −7,743 | $94.98 | $735K | 177,216 |
| 2017-12-07 | OYLER JOHN Chief Executive Officer | Sale | −5,162 | $96.12 | $496K | 172,054 |
| 2017-12-07 | OYLER JOHN Chief Executive Officer | Sale | −100 | $96.66 | $10K | 171,954 |
| 2017-12-06 | OYLER JOHN Chief Executive Officer | Sale | −8,000 | $91.48 | $732K | 255,137 |
| 2017-12-06 | OYLER JOHN Chief Executive Officer | Sale | −18,046 | $92.36 | $1.7M | 237,091 |
| 2017-12-06 | OYLER JOHN Chief Executive Officer | Sale | −4,000 | $93.02 | $372K | 233,091 |
| 2017-12-06 | OYLER JOHN Chief Executive Officer | Sale | −1,400 | $93.96 | $132K | 231,691 |
| 2017-12-04 | Huang Jane CMO, Hematology | Sale | −1,100 | $86.00 | $95K | 0 |
| 2017-11-29 | OYLER JOHN Chief Executive Officer | Sale | −36,340 | $82.92 | $3.0M | 263,137 |
| 2017-11-28 | OYLER JOHN Chief Executive Officer | Sale | −32,985 | $85.52 | $2.8M | 299,477 |
| 2017-11-27 | OYLER JOHN Chief Executive Officer | Sale | −16,346 | $86.75 | $1.4M | 332,697 |
| 2017-11-27 | OYLER JOHN Chief Executive Officer | Sale | −235 | $87.49 | $21K | 332,462 |
Page 115 of 123 · 2,455 trades